Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 4/20 | 0.39 |
| ▸ | PPARG | P37231 | 4/20 | 0.36 |
| ▸ | PTPN5 | P54829 | 4/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.31 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
| ▸ | RORA | P35398 | 1/20 | 0.30 |
| ▸ | RORC | P51449 | 1/20 | 0.30 |
| ▸ | RORB | Q92753 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21116268 | 0.85 | KIF11 (0.40) | KIF11PPARGPPARANPY5RRORA | |
| SCHEMBL10090573 | 0.85 | KIF11 (0.40) | KIF11PPARGPPARANPY5RRORA | |
| SCHEMBL21116258 | 0.85 | KIF11 (0.40) | KIF11 | |
| SCHEMBL21116535 | 0.83 | KIF11 (0.52) | KIF11PPARGPPARA | |
| SCHEMBL10090543 | 0.80 | KIF11 (0.36) | KIF11PPARGPPARANPY5RRORA | |
| SCHEMBL21116538 | 0.79 | KIF11 (0.44) | KIF11PPARGPPARA | |
| SCHEMBL19953880 | 0.79 | KIF11 (0.37) | KIF11PPARGRORARORCRORB | |
| SCHEMBL20052627 | 0.78 | PPARG (0.40) | KIF11PPARGPTPN5PPARA | |
| SCHEMBL21116900 | 0.78 | KIF11 (0.46) | KIF11PPARGPPARANPY5R | |
| SCHEMBL26180242 | 0.78 | PPARG (0.44) | KIF11PPARGPPARARORARORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, NOX3, ORC3 | KIF11 3544/4885PPARG 3493/4885PTPN5 2951/4885 |
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | OR10J3, ORC3, NOX3 | KIF11 3520/4885PPARG 3659/4885PTPN5 2989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.